Synapse

← Charles M. Perou

Papers by Charles M. Perou

Page 6 · newest first

  1. Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb ComplexCancer Discovery · 2017
  2. Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formationJournal of Clinical Investigation · 2017
  3. Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast CancerNano Letters · 2016
  4. Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple MetastasesPLoS Medicine · 2016
  5. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin ResponsivenessJNCI Journal of the National Cancer Institute · 2016
  6. A PAM50-Based Chemoendocrine Score for Hormone Receptor–Positive Breast Cancer with an Intermediate Risk of RelapseClinical Cancer Research · 2016
  7. Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and TumorigenesisMolecular Cancer Research · 2016
  8. The molecular basis of breast cancer pathological phenotypesThe Journal of Pathology · 2016
  9. Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 TrialJNCI Journal of the National Cancer Institute · 2016
  10. Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V’DJerBioinformatics · 2016
  11. Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor TypesJNCI Journal of the National Cancer Institute · 2016
  12. Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung CancerCancer Discovery · 2016
  13. Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two CohortsClinical Cancer Research · 2016
  14. Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast CancersCancer Research · 2016
  15. High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer SubtypeClinical Cancer Research · 2016
  16. Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data setnpj Breast Cancer · 2016
  17. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene AssaysRadiology · 2016
  18. DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlasnpj Breast Cancer · 2016
  19. Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast CancerPLoS ONE · 2016
  20. Overview of Genetically Engineered Mouse Models of Distinct Breast Cancer SubtypesCurrent Protocols in Pharmacology · 2016
  21. Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-studyBreast Cancer Research and Treatment · 2016
  22. PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)npj Breast Cancer · 2016
  23. Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53 deficient mammary cancersDisease Models & Mechanisms · 2016
  24. Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER ConsortiumCancer Epidemiology Biomarkers & Prevention · 2015
  25. The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3pNature Communications · 2015
  26. An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in CancerMolecular & Cellular Proteomics · 2015
  27. Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapyBMC Medicine · 2015
  28. Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating AgentsCell Reports · 2015
  29. Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without LapatinibJournal of Clinical Oncology · 2015
  30. αB-crystallin expression in breast cancer is associated with brain metastasisnpj Breast Cancer · 2015
  31. Validation of the Lung Subtyping Panel in Multiple Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Lung Tumor Gene Expression Data SetsArchives of Pathology & Laboratory Medicine · 2015
  32. Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial CellsSHILAP Revista de lepidopterología · 2015
  33. Development and verification of the PAM50-based Prosigna breast cancer gene signature assayBMC Medical Genomics · 2015
  34. Palbociclib — Taking Breast-Cancer Cells Out of GearNew England Journal of Medicine · 2015
  35. Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 ActivationCell Reports · 2015
  36. Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)JNCI Journal of the National Cancer Institute · 2015
  37. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancerBreast Cancer Research and Treatment · 2015
  38. TU-AB-BRA-08: Radiomics in the Analysis of Breast Cancer Heterogeneity On DCE-MRIMedical Physics · 2015
  39. Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer*Molecular & Cellular Proteomics · 2015
  40. Proper Use of Allele-Specific Expression Improves Statistical Power forcis-eQTL Mapping with RNA-Seq DataJournal of the American Statistical Association · 2015
  41. Abstract S2-04: Comprehensive molecular characterization of invasive lobular breast tumorsCancer Research · 2015
  42. c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expressionOncotarget · 2015
  43. Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor ExpressionThe Oncologist · 2015
  44. CCR 20th Anniversary Commentary: The Development of Breast Cancer Molecular SubtypingClinical Cancer Research · 2015
  45. Intratumoral Heterogeneity in a Trp53 -Null Mouse Model of Human Breast CancerCancer Discovery · 2015
  46. Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapyBreast Cancer Research and Treatment · 2015
  47. Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Germline Pharmacogenetic StudiesJNCI Journal of the National Cancer Institute · 2014
  48. Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survivalAnnals of Oncology · 2014
  49. Differentiation and Loss of Malignant Character of Spontaneous Pulmonary Metastases in Patient-Derived Breast Cancer ModelsCancer Research · 2014
  50. Effect of p95HER2/611CTF on the Response to Trastuzumab and ChemotherapyJNCI Journal of the National Cancer Institute · 2014